1. Home
  2. OMH vs CHEK Comparison

OMH vs CHEK Comparison

Compare OMH & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • CHEK
  • Stock Information
  • Founded
  • OMH 2015
  • CHEK 2004
  • Country
  • OMH Singapore
  • CHEK Israel
  • Employees
  • OMH N/A
  • CHEK N/A
  • Industry
  • OMH Real Estate
  • CHEK Medical Electronics
  • Sector
  • OMH Finance
  • CHEK Health Care
  • Exchange
  • OMH Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • OMH 4.6M
  • CHEK 4.0M
  • IPO Year
  • OMH 2023
  • CHEK 2015
  • Fundamental
  • Price
  • OMH $2.11
  • CHEK $0.67
  • Analyst Decision
  • OMH Strong Buy
  • CHEK
  • Analyst Count
  • OMH 1
  • CHEK 0
  • Target Price
  • OMH $15.00
  • CHEK N/A
  • AVG Volume (30 Days)
  • OMH 404.8K
  • CHEK 22.2K
  • Earning Date
  • OMH 01-01-0001
  • CHEK 05-14-2025
  • Dividend Yield
  • OMH N/A
  • CHEK N/A
  • EPS Growth
  • OMH N/A
  • CHEK N/A
  • EPS
  • OMH N/A
  • CHEK N/A
  • Revenue
  • OMH $5,390,607.00
  • CHEK N/A
  • Revenue This Year
  • OMH $102.52
  • CHEK N/A
  • Revenue Next Year
  • OMH $37.92
  • CHEK N/A
  • P/E Ratio
  • OMH N/A
  • CHEK N/A
  • Revenue Growth
  • OMH 25.77
  • CHEK N/A
  • 52 Week Low
  • OMH $0.25
  • CHEK $0.56
  • 52 Week High
  • OMH $3.35
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • OMH 49.97
  • CHEK 41.37
  • Support Level
  • OMH $1.70
  • CHEK $0.64
  • Resistance Level
  • OMH $3.77
  • CHEK $0.71
  • Average True Range (ATR)
  • OMH 0.44
  • CHEK 0.06
  • MACD
  • OMH -0.04
  • CHEK 0.00
  • Stochastic Oscillator
  • OMH 19.81
  • CHEK 31.06

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: